Thomas A. MCCOURT - Jan 17, 2024 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Jan 17, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 04:05 PM
Previous filing
Jun 8, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +250K +32.83% $0.00 1.01M Jan 17, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 26, 2021 and June 7, 2021. The earned PSUs were certified and vested on January 17, 2024.
F2 The reporting person acquired 2,037 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2023.